NEW MOBILE APP!
View medications, request prescription refills, and get status updates! Securely chat with our pharmacy staff, enter your insurance information, upload insurance cards, and transfer in prescriptions from other pharmacies!

Download our pharmacy app today! Click here to get started
2673 Highway 644, Suite 1, Louisa, KY 41230 Phone: (606) 638-9627 Mon-Fri 9:00am - 6:00pm | Sat 9:00am - 3:00pm | Sun Closed
Rite-Value Pharmacy Logo

Get Healthy!

Popularity of Psilocybin, Psychedelics Hasn't Increased ER Visits
  • Posted November 21, 2025

Popularity of Psilocybin, Psychedelics Hasn't Increased ER Visits

Increased use of hallucinogens like psilocybin hasn’t created an increase in ER visits or hospitalizations for bad trips, researchers recently reported in JAMA Network Open.

“In fact, after a small rise through early 2020, admissions declined through 2023, with no correlation to decriminalization policies,” senior researcher Dr. Kevin Xu, an assistant professor of psychiatry at Washington University School of Medicine in St. Louis, Missouri, said in a news release.

Hallucinogen use is rising in the United States, researchers said in background notes. Oregon and Colorado have decriminalized the use of psilocybin, along with several cities in Massachusetts, California and Michigan.

However, it’s not clear how that increase has affected the health of users, researchers said.

For the study, researchers tracked ER visits and hospital admissions for substance use involving people 16 to 64 between 2016 and 2023.

Among more than 1.3 million people treated for substance use, fewer than 2% had taken hallucinogens, researchers found.

The monthly share of hallucinogen-related admissions ranged from 0.6% in January 2016 to a high of nearly 1.2% in January 2021.

ER visits and hospitalizations currently have stabilized into a pattern that’s slightly above pre-pandemic levels, results show.

“Hallucinogens continue to account for a small fraction of substance-related hospital admissions, outweighed by alcohol- and opioid-related encounters,” the research team concluded in their report.

“These findings add important context to other studies showing rises in hallucinogen use," researcher Richard Grucza, a professor of family and community medicine and health outcomes research at Saint Louis University School of Medicine, said in a news release.

“Those increases don't seem to be contributing to rising ER visits, and if anything, alcohol and other drugs seem to be driving adverse consequences of psychedelic use,” Grucza said.

More information

The Cleveland Clinic has more on hallucinogens.

SOURCES: Saint Louis University, news release, Nov. 18, 2025; JAMA Network Open, Nov. 18, 2025

HealthDay
Health News is provided as a service to Rite-Value Pharmacy site users by HealthDay. Rite-Value Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.